TrialWiener klinische Wochenschrift2017

Filgrastim-alone versus pegylated filgrastim-alone for autologous peripheral blood stem cells mobilization in newly diagnosed multiple myeloma patients.

Barbara Skopec et al.PubMed ↗Publisher ↗

No numbers read from the abstract.